NCT05363267 2026-01-13
NF-1, Nutraceutical Intervention
Masonic Cancer Center, University of Minnesota
Phase 1 Active not recruiting
Clinical Trials
8 trialsNCT05677594 2026-01-12
Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1
Johns Hopkins University
Active not recruiting
NCT05581511 2025-10-14
cNF Natural Hx
Johns Hopkins University
Active not recruiting
NCT02964884 2025-06-24
Interventions for Reading Disabilities in NF1
Vanderbilt University
Phase 2 Active not recruiting
NCT04481048 2024-10-09
DoDNAC
Children's Hospital Medical Center, Cincinnati
Phase 2 Active not recruiting
NCT03741101 2024-04-11
plexifpc
Region Skane
Phase 2 Active not recruiting
NCT03363217 2023-11-27
Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.
St. Justine's Hospital
Phase 2 Active not recruiting
NCT03820778 2021-03-02
Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1
Children's National Research Institute
Phase NA Active not recruiting